| 2.60 Delayed Data As of Nov 19 |  -0.06 / -2.26%Today’s Change | 2.25 Today|||52-Week Range 8.24 | -29.35% Year-to-Date |
| Previous close | 2.66 |
| Today’s open | 2.66 |
| Day’s range | 2.60 - 2.74 |
| Volume | 2,702 |
| Average volume (3 months) | 19,909 |
| Market cap | $48.3M |
| Earnings growth (last year) | -119.54% |
| Earnings growth (this year) | +1.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -59.27% |
| P/E ratio | NM |
| Price/Sales | 72.29 |
| Price/Book | 0.81 |
| Today’s change | Today’s % change | |
|---|---|---|
| KZRKezar Life Sciences ... | -0.04 | -1.57% |
| PSTIPluristem Therapeuti... | -0.02 | -0.62% |
| INMBINmune Bio Inc | +0.16 | +3.78% |
| AQBAquaBounty Technolog... | -0.06 | -2.72% |
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $705.0K |
| Annual profit (last year) | -$36.5M |
| Net profit margin | -5,175.46% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
